You are here

Article metrics

Article menu

Download PDFPDF

Poster Presentation
CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2026

AbstractFullPdf
Dec 2019010
Jan 2020042
Feb 2020032
Mar 2020002
May 2020041
Jun 20200100
Jul 2020031
Aug 2020011
Sep 2020050
Oct 2020011
Nov 2020041
Dec 2020020
Jan 2021021
Feb 2021011
Mar 2021001
Apr 2021020
May 2021022
Jun 2021002
Jul 2021035
Aug 2021001
Sep 2021031
Oct 20210314
Nov 20210413
Dec 2021030
Jan 2022041
Feb 2022012
Mar 2022021
May 20220128
Jun 2022044
Jul 2022020
Aug 2022031
Sep 2022046
Oct 2022013
Nov 2022031
Dec 2022071
Jan 2023011
Feb 2023020
Mar 2023030
Apr 2023010
May 2023001
Jun 2023020
Jul 2023026
Sep 2023043
Oct 2023011
Nov 2023021
Dec 2023061
Jan 2024020
Feb 2024071
Mar 20240243
Apr 20240420
May 2024023
Jul 2024070
Aug 2024041
Sep 2024043
Oct 20240135
Nov 20240214
Dec 20240131
Jan 20250917
Feb 2025012
Mar 20250124
Apr 20250122
May 20250815
Jun 20250105
Mar 2026010
Total0260220